Joel R. Rosh
Expertise in
5
conditions

Dr. Joel R. Rosh

Pediatric Gastroenterology
1991 Marcus Avenue, Suite M100, 
Lake Success, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Referral may be required
Before you request
Expertise in
5
conditions
1991 Marcus Avenue, Suite M100, 
Lake Success, NY 

Overview

Joel Rosh is a Pediatric Gastroenterologist practicing medicine in Lake Success, New York.

Dr. Rosh is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Crohn's Disease, Colitis, Endoscopy, and Colonoscopy.

Dr. Rosh is board certified in American Board Of Pediatrics/Gastroenterology. He is actively involved in clinical research, co-authoring 104 peer reviewed articles and participating in 5 clinical trials. Dr. Rosh is currently accepting new patients.

Specialties

Pediatric Gastroenterology

Licenses

Pediatric Gastroenterology in NJ

Board Certifications

American Board Of Pediatrics/Gastroenterology

Fellowships

Icahn School of Medicine At Mount Sinai

Hospital Affiliations

Hofstra/Northwell School Of Medicine/Nursing
North Shore University Hospital
Long Island Jewish Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northwell Health
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Cohen Children's Northwell Health Physician Partners at Lake Success
1991 Marcus Avenue, Suite M100, Lake Success, NY 11042

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Recruiting
Publish Date: May 05, 2026
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Completed
Publish Date: March 26, 2024
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Not Applicable
View 4 Less Clinical Trials

104 Total Publications

Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg.
Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg.
Journal: Journal of Crohn's & colitis
Published: March 17, 2026
Similar Doctors
Expertise in
9
conditions
Dr. Mirna Chehade
Pediatric Gastroenterology
Expertise in
9
conditions
Dr. Mirna Chehade
Pediatric Gastroenterology
Referral may be required

Mount Sinai

1 Gustave L Levy Pl, 
New York, NY 
 (13.8 miles away)
212-241-4880
Languages Spoken:
English
See accepted insurances

Mirna Chehade is a Pediatric Gastroenterologist practicing medicine in New York, New York. Dr. Chehade is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Eosinophilic Esophagitis, Esophagitis, Gastritis, Eosinophilic Enteropathy, and Endoscopy.

Expertise in
8
conditions
Dr. Marla C. Dubinsky
Pediatric Gastroenterology
Expertise in
8
conditions
Dr. Marla C. Dubinsky
Pediatric Gastroenterology
Referral may be required

Susan & Leonard Feinstein IBD Clinical Center

17 E 102nd St Fl 5, 
New York, NY 
 (13.4 miles away)
212-257-0031
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marla Dubinsky is a Pediatric Gastroenterologist practicing medicine in New York, New York. Dr. Dubinsky is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Endoscopy, and Colonoscopy. Dr. Dubinsky is currently accepting new patients.

Expertise in
5
conditions
Dr. Michael T. Dolinger
Pediatric Gastroenterology
Expertise in
5
conditions
Dr. Michael T. Dolinger
Pediatric Gastroenterology
Referral may be required

Mount Sinai

1 Gustave L Levy Pl, 
New York, NY 
 (13.8 miles away)
212-241-5415
Languages Spoken:
English
See accepted insurances

Michael Dolinger is a Pediatric Gastroenterologist practicing medicine in New York, New York. Dr. Dolinger is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Ulcerative Colitis, Hemorrhagic Proctocolitis, Endoscopy, and Colonoscopy.

Frequently Asked Questions about Dr. Joel R. Rosh

How do I make an appointment with Dr. Joel R. Rosh?

You can book an appointment with Dr. Joel R. Rosh by calling their office at 516-472-3650. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joel R. Rosh a top-rated expert for Viral Gastroenteritis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joel R. Rosh is classified as an Elite expert for Viral Gastroenteritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joel R. Rosh specialize in?

While Dr. Joel R. Rosh is a Pediatric Gastroenterology, they have specific expertise in Viral Gastroenteritis, Crohn's Disease, and Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Gastroenterology.

Does Dr. Joel R. Rosh participate in research or clinical trials?

Yes. Dr. Joel R. Rosh has published 104 articles and abstracts on conditions like Viral Gastroenteritis. You can view a list of Dr. Joel R. Rosh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joel R. Rosh accept my insurance?

Dr. Joel R. Rosh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 516-472-3650 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosh's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile